title: The NF-κB signaling pathway: an important therapeutic target in psychiatric disorders.
authors.affiliation: Department of Immunology, Experimental Medicine Research Institute, Istanbul University, Istanbul, Turkey.
authors.forename: M A
authors.initials: MA
authors.lastname: Altinoz
authors.affiliation: Department of Psychiatry, Bakirkoy Education and Research Hospital for Psychiatry, Istanbul, Turkey.
authors.forename: B
authors.initials: B
authors.lastname: Ince
authors.affiliation: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
authors.forename: C
authors.initials: C
authors.lastname: Tek
authors.affiliation: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
authors.forename: V H
authors.initials: VH
authors.lastname: Srihari
authors.affiliation: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.|Department of Psychiatry and Psychology, Maastricht University Medical Centre, Maastricht, The Netherlands.
authors.forename: S
authors.initials: S
authors.lastname: Guloksuz
mesh_terms: D006801:Humans; D001523:Mental Disorders / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism* / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology
chemical_list: D016328:NF-kappa B